Homeopathy最新文献

{"title":"Women in Homeopathy.","authors":"Robert T Mathie","doi":"10.1055/s-0043-1767817","DOIUrl":"https://doi.org/10.1055/s-0043-1767817","url":null,"abstract":"As stated on our publisher’swebsite, “Morewomen than ever before are choosing to pursue careers in both medicine and medical research; however, a gender gap still exists. According to the UN, women make up 70% of health and social care workers, but only 37% of first authors on medical research articles. At Thieme, we believe the key to closing the gender gap in medicine is to uplift women’s voices”.1 Thieme has therefore created its Women in Medicine collection, “which aims to highlight and celebrate the work and contributions to medicine by female-identifying people from around the world”. Our journal is supporting this important project through its connected Women in Homeopathy collection, available to view via the Authors tab on the homepage. Akin to the format of a Virtual Special Issue, its content is articles published in Homeopathy from 2022 onward that have prominently female authorship. We hope that the new online collection adds encouragement to women to continue in homeopathy research and to submit ever more work to the journal. The contribution by women has been a stand-out feature of Homeopathy for many years, and female authorship is again well represented in this current issue of the journal. Each of the first two papers is a randomised controlled trial (RCT) in humans, on the novel topics of ringworm and hyperuricemia, with inconclusive and positive findings respectively.2,3 An international survey on the uptake and prevalence of the use of repertory software among homeopathy practitioners is the topic of our third article.4 The ever-eclectic nature of homeopathy research is reflected in the remaining papers: an RCT on homeopathic products as a complementary dietary additive for pigs5; an in-vitro experiment on the antimicrobial activity of dynamised essential oil of the medicinal plant Aloysia polystachya6; and the laboratory development of a method to immobilise solvatochromic dyes on cellulose films that will refine the investigation of dye–potency interactions.7 The issue is suitably completed by a clinical case report, from an allfemale group of authors, detailing the effective use of homeopathy to treat a woman with multiple chronic conditions.8","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"112 2","pages":"73"},"PeriodicalIF":1.7,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9538472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Immobilization of Solvatochromic Dyes on Transparent Cellulose Films: an Improved Method for the Study of Homeopathic Potencies.","authors":"Steven J Cartwright","doi":"10.1055/s-0042-1751255","DOIUrl":"https://doi.org/10.1055/s-0042-1751255","url":null,"abstract":"<p><strong>Background: </strong>Highly diluted and succussed solutions (homeopathic potencies) have been shown to interact with a wide range of solvatochromic dyes based on changes in their UV-visible spectra. Studies so far have involved free dyes in solution, but there is a pressing need to find ways to investigate the potency-dye interaction using isolated dye molecules to ask more searching physico-chemical questions regarding the fundamental nature of potencies.</p><p><strong>Aims and methods: </strong>The aims of the present study have been to look for ways to covalently immobilize solvatochromic dyes onto transparent cellulose films and hence be in a position to investigate dye-potency interactions without the complication of dye-dye interactions, including dye aggregation, which can occur with free dyes in solution.</p><p><strong>Results: </strong>To date, a total of nine different dyes have been immobilized on cellulose films using epoxide activation of hydroxyl groups on the cellulose surface. Using this method, studies have begun looking at the time course of potency action on one of these immobilized dyes, Brooker's merocyanine. Results show that the interaction of <i>Arsenicum</i> 10M with this dye consists of three phases-an initial growth phase, a sustained plateau of interaction, and a final decline phase lasting several days.</p><p><strong>Conclusion: </strong>A method has been developed that successfully immobilizes solvatochromic dyes onto transparent cellulose film. These films can then be used in a spectrophotometer to study at a much more detailed level how potencies interact with dyes compared with using free dyes in solution. Results indicate that the information gained in this way provides new insights regarding the fundamental nature of potencies. Specifically, studies using immobilized Brooker's merocyanine with <i>Arsenicum</i> 10M reveal that the lifetime of the potency is much longer than expected and that its action consists of three distinct phases, suggesting a resonant interaction with the dye. How resonant interaction might help to explain the clinical action of potencies is discussed.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"112 2","pages":"125-134"},"PeriodicalIF":1.7,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9947234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Multimorbidity in a 35-Year-Old Female Patient Treated with Homeopathy: A Case Report.","authors":"Jayasubhashini Mallangi,&nbsp;Jyotika Chaudhuri,&nbsp;Roja Varanasi,&nbsp;Praveen Oberai","doi":"10.1055/s-0042-1749594","DOIUrl":"https://doi.org/10.1055/s-0042-1749594","url":null,"abstract":"<p><strong>Background: </strong>Multimorbidity, a prevailing trend in the primary care population of all ages, is a challenge for health care systems that are largely configured for single disease management. Homeopathy has shown competence in the management of chronic diseases, whether they occur as a single ailment or as a multimorbidity.</p><p><strong>Case history: </strong>A 35-year-old female patient presenting with hemorrhoids, low back pain, hypothyroidism, fibroadenosis breasts (bilateral), and fibroid uterus was given homeopathic treatment for 33 months at Nandigama AYUSH Lifestyle Disorders Clinic, Andhra Pradesh. She was prescribed the homeopathic medicines <i>Lachesis mutus</i> and <i>Thyroidinum</i> at different time intervals based on the totality of symptoms.</p><p><strong>Results: </strong>Following treatment, a reduction in the size of the uterine fibroid and complete regression of breast lumps in ultrasonography were noted. The modified Naranjo criteria total score was 10 out of 13. Further, significant improvement in symptoms and laboratory parameters, such as triiodothyronine (T3), tetra-iodothyronine (T4), and thyroid-stimulating hormone (TSH), indicated that a well-chosen homeopathic medicine may be beneficial in managing multimorbidity.</p><p><strong>Conclusion: </strong>This case study reveals a positive role of homeopathic treatment in multimorbidity. More case studies and well-designed controlled research should be used to further investigate homeopathic intervention in multimorbidity.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"112 2","pages":"135-142"},"PeriodicalIF":1.7,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9947238","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Homeopathic Products as a Complementary Dietary Additive for Pigs in their Growing and Finishing Phases.","authors":"Geraldyne Nunes Wendt,&nbsp;Jansller Luiz Genova,&nbsp;Liliana Bury de Azevedo,&nbsp;Paulo Evaristo Rupolo,&nbsp;Cristine Regina Gregory,&nbsp;Josiane Aparecida Volpato,&nbsp;Silvana Teixeira Carvalho,&nbsp;Paulo Levi de Oliveira Carvalho,&nbsp;Tiago Junior Pasquetti","doi":"10.1055/s-0042-1749147","DOIUrl":"10.1055/s-0042-1749147","url":null,"abstract":"<p><strong>Background: </strong>Homeopathic products (HP) have been proposed for the prevention of disease and as a complementary dietary additive in pig farming, with resulting improved performance and quality of life of the animals and with benefits for food safety. The aim of this study was to assess the addition of HP to pig feed and its effects on growth performance, dietary protein utilization, nutrient digestibility, meat quality, and economic feasibility.</p><p><strong>Methods: </strong>A total of 80 male pigs, body weight 32.8±2.3kg, were allocated in a randomized design, with two treatments of 10 replications and four animals per experimental unit. Treatments were composed of a control diet (CD) or CD+HP (Finalvitaplus+Figotonus, 1.1kg/ton feed of each product). The outcome measures used were growth performance (body weight gain) and feed efficiency (body weight gain per unit of feed consumed), efficiency of dietary protein utilization (blood urea nitrogen), nutrient digestibility (apparent digestibility coefficient and apparent nutrient digestibility), meat quality (including pH, temperature, color, liquid loss by cooking and thawing, intramuscular fat and meat tenderness), and economic feasibility (cost of the diets).</p><p><strong>Results: </strong>There was no effect (<i>p</i> >0.05) of treatments on growth performance of the pigs, though the group that received HP showed an 8.93% greater feed efficiency than the control group (<i>p</i>=0.077). The animals in the control group had a 14.37% higher blood urea nitrogen concentration in the finishing I phase (70-100kg body weight) compared with those fed HP (<i>p</i>=0.028), indicating lower protein utilization in the controls. There was comparative improvement in digestibility coefficient and in nutrient digestibility in pigs fed HP in the growing-finishing phase (<i>p</i> <0.05). There was no differential effect of treatments on meat quality or economic feasibility (<i>p</i> >0.05).</p><p><strong>Conclusion: </strong>The addition of HP to the diet of growing-finishing pigs produced some improvement in their dietary protein utilization, nutrient digestibility and feed efficiency, though it did not affect their growth performance, meat quality or economic feasibility.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"112 2","pages":"107-109"},"PeriodicalIF":1.7,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9578570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Individualized Homeopathic Medicines in the Treatment of Tinea Corporis: Double-Blind, Randomized, Placebo-Controlled Trial.","authors":"Bakibillah Laskar,&nbsp;Swapan Paul,&nbsp;Abhijit Chattopadhyay,&nbsp;Avaranjika Karuppusamy,&nbsp;Dharshna Balamurugan,&nbsp;Puja Bhakta,&nbsp;Sourav Das,&nbsp;Siddhartha Pal,&nbsp;Navin Kumar Singh,&nbsp;Munmun Koley,&nbsp;Subhranil Saha","doi":"10.1055/s-0042-1750799","DOIUrl":"https://doi.org/10.1055/s-0042-1750799","url":null,"abstract":"<p><strong>Introduction: </strong>Tinea corporis (TC; ringworm or dermatophytosis) is a superficial skin infection caused by <i>Microsporum</i>, <i>Epidermophyton</i> and <i>Trichophyton</i> genera of dermatophytes. We compared the effects of individualized homeopathic medicines (IHMs) in fifty-millesimal (LM) potencies against placebo in TC.</p><p><strong>Methods: </strong>A double-blind, randomized, placebo-controlled, two parallel arms trial was conducted on 62 individuals suffering from TC at the National Institute of Homoeopathy, India. Participants were randomized in a 1:1 ratio to receive either IHMs in LM potencies or identical-looking placebos for a period of 3 months. The primary outcome measure was the number of participants showing complete disappearance of skin lesions after 3 months. Secondary outcomes were a numeric rating scale (NRS) measuring intensity of itching and the Skindex-29 questionnaire (overall, and three sub-scales - degree of symptoms, psychological functioning, emotional status). All were assessed at baseline and every month, up to 3 months. The intention-to-treat sample was analyzed to detect inter-group differences using two-way repeated measures analysis of variance after adjusting for baseline differences.</p><p><strong>Results: </strong>The primary outcome revealed no improvement in either of the groups (<i>χ</i> ² = 0.012, <i>p</i> = 0.999). Inter-group differences in some of the secondary outcomes favored IHMs against placebo - itching NRS (mean group difference after 3 months: -0.7 (95% confidence interval [CI], -1.1 to -0.4; <i>p</i> = 0.001); Skindex-29 overall (mean group difference after 3 months: 3.2 [95% CI, -0.6 to 7.0; <i>p</i> = 0.009]); Skindex-29 degree of symptoms (mean group difference after 3 months: 0.9 [95% CI, -0.2 to 1.9; <i>p</i> = 0.007]); and Skindex-29 psychological functioning (mean group difference after 3 months: 1.7 [95% CI, 0-3.4; <i>p</i> = 0.002]).</p><p><strong>Conclusion: </strong>Results were negative on the primary outcome; however, secondary outcomes included some statistically significant results favoring IHMs against placebo after 3 months.</p><p><strong>Trial registration: </strong>CTRI/2019/11/021999; UTN: U1111-1242-0070.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"112 2","pages":"74-84"},"PeriodicalIF":1.7,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9566462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Searching for the Genus Epidemicus in Chinese Patients: Findings from the Clificol COVID-19 Clinical Case Registry.","authors":"Alexander Tournier,&nbsp;Yvonne Fok,&nbsp;Robbert van Haselen,&nbsp;Aaron To","doi":"10.1055/s-0042-1750380","DOIUrl":"https://doi.org/10.1055/s-0042-1750380","url":null,"abstract":"<p><strong>Background: </strong> The Clificol COVID-19 Support Project is an innovative international data collection project aimed at tackling some of the core questions in homeopathy. This paper reports on the further investigation of the genus epidemicus concept during the first wave of the pandemic in the Chinese population.</p><p><strong>Methods: </strong> The design is an observational clinical case registry study of Chinese patients with confirmed or suspected coronavirus disease 2019 (COVID-19). The symptoms were prospectively collected via a 150-item questionnaire. The concept of genus epidemicus, including the role of treatment individualization, was investigated by analyzing whether presenting symptoms clustered into distinct groups. Two standard statistical analysis techniques were utilized: principal component analysis for extracting the most meaningful symptoms of the dataset; the <i>k</i>-means clustering algorithm for automatically assigning groups based on similarity between presenting symptoms.</p><p><strong>Results: </strong> 20 Chinese practitioners collected 359 cases in the first half of 2020 (766 consultations, 363 prescriptions). The cluster analysis found two to be the optimum number of clusters. These two symptomatic clusters had a high overlap with the two most commonly prescribed remedies in these sub-populations: in cluster 1 there were 297 prescriptions, 95.6% of which were <i>Gelsemium sempervirens</i>; in cluster 2 there were 61 prescriptions, 95.1% of which were <i>Bryonia alba</i>.</p><p><strong>Conclusion: </strong> This is the first study to investigate the notion of genus epidemicus by using modern statistical techniques. These analyses identified at least two distinct symptom pictures. The notion of a single COVID-19 genus epidemicus did not apply in the studied population.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"112 1","pages":"30-39"},"PeriodicalIF":1.7,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/54/31/10-1055-s-0042-1750380.PMC9868965.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10600832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transition and Evolution in Homeopathy Research.","authors":"Robert T Mathie","doi":"10.1055/s-0042-1760101","DOIUrl":"10.1055/s-0042-1760101","url":null,"abstract":"","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"112 1","pages":"1-2"},"PeriodicalIF":1.2,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10618313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Contributing Reviewers in 2022.","authors":"","doi":"10.1055/s-0042-1760385","DOIUrl":"https://doi.org/10.1055/s-0042-1760385","url":null,"abstract":"","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"112 1","pages":"i-ii"},"PeriodicalIF":1.7,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9074420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The In-Vitro Effect of Homeopathically Prepared Rubus idaeus and 680 nm Laser Irradiation on Cervical Cancer Cells.","authors":"Kelley S Joubert,&nbsp;Blassan P George,&nbsp;Radmila Razlog,&nbsp;Heidi Abrahamse","doi":"10.1055/s-0042-1747683","DOIUrl":"https://doi.org/10.1055/s-0042-1747683","url":null,"abstract":"<p><strong>Background: </strong> Cervical cancer (CC) is the second leading cancer in women and is the most common in those aged 15 to 44 years. Medicinal plant extracts have been used as homeopathic preparations for health benefits. <i>Rubus idaeus</i> (<i>RI</i>) <i>is</i> used to treat disorders of the female genital tract and produces cytotoxic effects. However, the use of homeopathically prepared <i>RI</i> in combination with low level laser therapy has not previously been explored.</p><p><strong>Aim: </strong> The study aims to investigate the in-vitro effects of homeopathically prepared <i>RI</i> alone and in combination as a potential photosensitizer with Low-level laser irradiation (LLLI) at fluencies of 5, 10, and 15 J/cm².</p><p><strong>Methods: </strong> HeLa CC cells were treated with <i>RI</i> (D3, D6, and 30cH homeopathic preparations). Cells were then treated with <i>RI</i> IC₅₀ and 680 nm laser diode at 5, 10, and 15 J/cm² fluencies, and the results compared with untreated control cells. Trypan blue viability, lactate dehydrogenase (LDH) cytotoxicity, and adenosine triphosphate (ATP) proliferation assays were used to analyze the cellular dose-responses along with inverted microscopy, Hoechst staining and Annexin-V/PI staining.</p><p><strong>Results: </strong> <i>RI</i> D3 alone demonstrated an ability to reduce cellular viability to 59% and also to reduce ATP levels. The subsequent combined treatment protocol of <i>RI</i> D3 with all fluencies of laser demonstrated an increase in cellular ATP and increased LDH levels compared with the control.</p><p><strong>Conclusion: </strong> The increased ATP and LDH levels observed in the combined treatment protocol of 680 nm laser and <i>RI</i> D3 at fluencies of 5, 10 and 15 J/cm², show that the Warburg effect might have been induced in the CC cells - an increase in glucose uptake and the preferential production of lactate, even in the presence of oxygen. More research, including work on other cell lines, needs to be conducted to identify if <i>RI</i> and perhaps a different wavelength of laser irradiation could have potential in inducing cell death in cancer cells.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"112 1","pages":"50-56"},"PeriodicalIF":1.7,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10563713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Homeopathic Treatment in Patients with COVID-19: Analysis of Clinical Evolution and Comparison between Cases in 2020 and 2021.","authors":"Fernanda Maria Simões da Costa Fujino,&nbsp;Ana Amélia Campos Claro Olandim,&nbsp;Jennifer Anne Coggan,&nbsp;Antonio Deusany de Carvalho Junior,&nbsp;Adriana de Queiroz Soares Bufalo,&nbsp;Eduardo Nishimiya Takeyama,&nbsp;Soraya Cristina Sant'Ana,&nbsp;Vagner Doja Barnabé,&nbsp;Nilson Roberti Benites","doi":"10.1055/s-0042-1749447","DOIUrl":"https://doi.org/10.1055/s-0042-1749447","url":null,"abstract":"<p><strong>Background: </strong> The manifestations of coronavirus disease 2019 (COVID-19) can result in several prognoses and lead patients to look for appropriate complementary or alternative treatment options according to their personal situation and available health care. Patients with mild symptoms or those who have not yet reached the maximum severity of their condition are those who seek outpatient care, where homeopathic treatment might be considered, given the well documented history of this medical system in several epidemics in the past.</p><p><strong>Objective: </strong> The aim of this study was to compare the homeopathic treatment used for symptomatic cases of COVID-19 in March and April 2020 with cases treated in March and April 2021.</p><p><strong>Method: </strong> This is a retrospective observational study based on the analysis of the medical records of symptomatic COVID-19 patients treated on an outpatient basis with homeopathy at the Hahnemanniano George Galvão Institute in São Paulo, Brazil. We analyzed 54 cases, divided into two samples (27 cases in each year), similar in relation to age, gender and origin of the patients.</p><p><strong>Results: </strong> The development was distinct in the 2 years, with improvement of symptoms after 3 days of the first homeopathic prescription in 2020 whilst in 2021 the improvement occurred from the sixth day onward. The most frequently prescribed homeopathic medicine also differed in the two samples (<i>Antimonium tartaricum</i> in 2020; <i>Arsenicum album</i> in 2021), which indicates the different disease characteristics at these two moments of the epidemic.</p><p><strong>Conclusion: </strong> In 2020, the symptomatology of the cases was mainly acute and the main medicine was <i>Antimonium tartaricum</i>. By comparison, in 2021 a greater interference from individuals' previous chronic miasmatic disease may explain the change in the main medicines used that year, with <i>Arsenicum album</i> being the most prescribed in the cases studied.</p>","PeriodicalId":13227,"journal":{"name":"Homeopathy","volume":"112 1","pages":"3-11"},"PeriodicalIF":1.7,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9136352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}